All Type of News
Profile of bureau directors of KFDA
KIM HAENG-JIN, KFDA Planning Officer.
He (51) is known as a man of moderate and attentive consideration to his juniors, but very tough in his job performance. He was graduated from Choongang Univ. college ...
KPhA standing commissions reshuffled
For promotion of organization efficiency the KPhA launched restructuring the body to 17 standing commissions including the special commission, by discontinuing the information commission for transfer of...
Strengthening competitiveness by strategic tie-up
So far a doc business cooperation between a domestic and foreign invested company has been proceeded mainly in aiming to reciprocate and share complementarily their products and sales powers. By taking an oppo...
Pharm. Firms hold shareholder's meeting
OVERVIEW.
13 leading pharmaceutical firms listed in the public stock exchange board including Dong-A, Green-Cross and Yuhan held shareholder's meetings. on Mar. 13th.
In the shareholder's meetings, mo...
Drug reclassification and its perspective.
STATUS.
The MOHW recognized necessity for an introduction of the separation system in the medical and pharmacy practice and a drug reclassification at the time of loud disputes between pharmacists and oriental ...
Sales to retail pharmacy declined
A chronic pharmaceutical recession ensued on remarkable changes in pharmaceutical distribution structures. Since the second half of 1997 the retail pharmacy business backslid and therefore the direct sales deal ...
Nominated to deputy administrator of KFDA
Mr. Kim Hee-sun, the former secretary of President in charge of the health and welfare affairs, was promoted to the deputy administrator (1st grade official) of KFDA, it was announced on Mar. 12th. The head of the ...
New pharmacists hardly find jobs
The IMF economic crisis hit a heavy blow to the recruitment of new pharmacists in pharmaceutical industry. Most of company announced their freezing policy in new employment of pharmacists and reducing number ...
Strategic tie-up between yuhan and Dong-A
3-year's 10 billion Won investment for development of an anti-osteoporosis drug.
Two leading pharmaceutical companies, Yuhan (Representative: Kim Sun-jin) and Dong-A (Representative: Yu Choong-shik) ag...
KPhA nominated 7 vice presidents
7 Vice presidents, Mr. Moon Woong-dae, Mr. Ju Sang-jae, Ms. Park Jung-ja, Mr. Kim Ku, Mr. Moon Jae-bin, Mr. Kim Kwang-ki and Mr. Kim Jae-ho were newly appointed on Mar. 5th.
KPhA also nominated Mr. Won Hee-mok a...
